These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 22178534)

  • 1. European initiative towards quality standards in education and training for discovery, development and use of medicines.
    Klech H; Brooksbank C; Price S; Verpillat P; Bühler FR; Dubois D; Haider N; Johnson C; Lindén HH; Payton T; Renn O; See W
    Eur J Pharm Sci; 2012 Apr; 45(5):515-20. PubMed ID: 22178534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. on-course(®) portal: a tool for in-service training and career development for biomedical scientists.
    Payton A; Janko C; Renn O; Hardman M;
    Drug Discov Today; 2013 Sep; 18(17-18):803-6. PubMed ID: 23597757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards a European strategy for medicines research (2014-2020): The EUFEPS position paper on Horizon 2020.
    Gaspar R; Aksu B; Cuine A; Danhof M; Takac MJ; Linden HH; Link A; Muchitsch EM; Wilson CG; Ohrngren P; Dencker L
    Eur J Pharm Sci; 2012 Dec; 47(5):979-87. PubMed ID: 23046836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A proposal for reforming psychologists' training in France and in the European Union].
    Bouchard JP
    Encephale; 2009 Feb; 35(1):18-24. PubMed ID: 19250989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Course fees and academic ranking: insights from the IMI EMTRAIN on-course® database.
    Payton A; Dallakian P; Fitton A; Payton A; Hardman M; Yuille M
    Drug Discov Today; 2014 Jul; 19(7):830-3. PubMed ID: 24325828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The Innovative Medicine Initiative (IMI)].
    Bril A; Canet E
    Med Sci (Paris); 2008 Oct; 24(10):885-90. PubMed ID: 18950588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What do pharmaceutical industry professionals in Europe believe about involving patients and the public in research and development of medicines? A qualitative interview study.
    Parsons S; Starling B; Mullan-Jensen C; Tham SG; Warner K; Wever K
    BMJ Open; 2016 Jan; 6(1):e008928. PubMed ID: 26743701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A research roadmap for complementary and alternative medicine - what we need to know by 2020.
    Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B
    Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategic framework for education and training in Quality by Design (QbD) and process analytical technology (PAT).
    de Matas M; De Beer T; Folestad S; Ketolainen J; Lindén H; Lopes JA; Oostra W; Weimer M; Öhrngren P; Rantanen J
    Eur J Pharm Sci; 2016 Jul; 90():2-7. PubMed ID: 27112991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges to pharmaceutical policymaking: lessons from Australia's national medicines policy.
    Lipworth W; Doran E; Kerridge I; Day R
    Aust Health Rev; 2014 May; 38(2):160-8. PubMed ID: 24589424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Network on veterinary medicines initiated by the European Federation For Pharmaceutical Sciences.
    Mochel JP; Tyden E; Hellmann K; Vendrig JC; Şenel S; Dencker L; Cristina RT; Linden H; Schmerold I
    J Vet Pharmacol Ther; 2018 Jun; 41(3):378-383. PubMed ID: 29266320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eliciting views of Australian pharmaceutical industry employees on collaboration and the concept of Quality Use of Medicines.
    Wang N; Lipworth WL; Ritchie JE; Williams KM; Day RO
    Intern Med J; 2011 Apr; 41(4):314-20. PubMed ID: 20403068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The NCI All Ireland Cancer Conference.
    Johnston PG; Daly PA; Liu E
    Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Past and future of an IMI-PharmaTrain (IMI-PhT)-initiated multinational pharmaceutical medicine course at the Semmelweis University in Hungary.
    Kerpel-Fronius S; Gottwald M; Arányi P; Renczes G; Görbe A; Papp R; Ferdinandy P
    Front Pharmacol; 2024; 15():1394987. PubMed ID: 38746014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategic funding priorities in the pharmaceutical sciences allied to Quality by Design (QbD) and Process Analytical Technology (PAT).
    Aksu B; De Beer T; Folestad S; Ketolainen J; Lindén H; Lopes JA; de Matas M; Oostra W; Rantanen J; Weimer M
    Eur J Pharm Sci; 2012 Sep; 47(2):402-5. PubMed ID: 22749874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-prescription medicines: a process for standards development and testing in community pharmacy.
    Benrimoj SC; Gilbert A; Quintrell N; Neto AC
    Pharm World Sci; 2007 Aug; 29(4):386-94. PubMed ID: 17333499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organization
    World Health Organ Tech Rep Ser; 2012; (970):1-235, back cover. PubMed ID: 22894011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. European Paediatric Formulation Initiative (EuPFI)-Formulating Ideas for Better Medicines for Children.
    Salunke S; Liu F; Batchelor H; Walsh J; Turner R; Ju TR; Tuleu C;
    AAPS PharmSciTech; 2017 Feb; 18(2):257-262. PubMed ID: 27422653
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.